WASHINGTON, March 24, 2015 /PRNewswire/ -- Edwards
Lifesciences Corporation (NYSE: EW), the global leader in the
science of heart valves and hemodynamic monitoring, announced that
Edwards' Chairman and CEO Michael A.
Mussallem today served as an invited expert panelist on
behalf of the Advanced Medical Technology Association (AdvaMed) at
the United States Senate Health, Education, Labor and Pensions
Committee hearing on "Continuing America's Leadership: Advancing
Research and Development for Patients."
"As medical technology innovators, it's our passion and mission
to continue developing better solutions to improve the lives of
patients," said Mussallem. "To maximize the impact of this
work, it is imperative that we forge a path toward revitalizing the
medical technology ecosystem in the
United States. Continued innovation is vital to improving
clinical outcomes, enhancing patients' quality of life and bringing
increased value to the healthcare system."
Mussallem noted collaborative engagement and significant
progress by the U.S. Food & Drug Administration (FDA) and
Centers for Medicare and Medicaid Services (CMS) in better
understanding and improving the predictability and approval
timelines for future generations of medical devices.
He also addressed opportunities to further reduce barriers in
regulatory approval and reimbursement, in order to help promote
America's continued worldwide leadership in medical device
development and also to support innovation. His comments
focused on three primary areas:
- the acceleration of FDA's vision to improve the regulatory
process;
- the need to strengthen the research and development
infrastructure so it is second to none; and
- continued encouragement of innovation by addressing issues
throughout the entire ecosystem.
Mussallem also drew upon Edwards' experience with the SAPIEN
transcatheter aortic heart valves to discuss the current regulatory
environment in the U.S.
To learn more about the hearing, view a webcast of the event or
read Mussallem's full written comments, visit
http://www.help.senate.gov/hearings/hearing/?id=97726068-5056-a032-5268-8f15ca25fd3b.
About Edwards Lifesciences
Edwards Lifesciences is the
global leader in the science of heart valves and hemodynamic
monitoring. Driven by a passion to help patients, the company
partners with clinicians to develop innovative technologies in the
areas of structural heart disease and critical care monitoring,
enabling them to save and enhance lives. Additional company
information can be found at www.edwards.com.
Edwards, Edwards Lifesciences, the stylized E logo and SAPIEN
are trademarks of Edwards Lifesciences Corporation. All other
trademarks are the property of their respective owners.
Logo - http://photos.prnewswire.com/prnh/20140714/126903
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/edwards-ceo-addresses-senate-committee-on-preserving-and-strengthening-medical-device-innovation-in-the-us-300055165.html
SOURCE Edwards Lifesciences Corporation